Table 3.
Relief of Clinical Symptoms and Laboratory Indicators Associated with NSCLC in Both Groups (Wilcoxon Test)
| Symptoms | Group A | Group B | P-value | ||||||
|---|---|---|---|---|---|---|---|---|---|
| SR | PR | NR | AG | SR | PR | NR | AG | ||
| Cough | 14 | 28 | 8 | 0 | 5 | 28 | 22 | 5 | 0.0001 |
| Chest pain | 16 | 25 | 9 | 0 | 6 | 25 | 24 | 5 | 0.0001 |
| Bloody sputum | 15 | 28 | 6 | 1 | 12 | 30 | 16 | 2 | 0.0524 |
| Chest tightness | 16 | 26 | 8 | 0 | 14 | 27 | 15 | 4 | 0.0653 |
| carcinoembryonic antigen/squamous cell carcinoma antigen | 15 | 28 | 7 | 0 | 3 | 26 | 25 | 6 | <0.0001 |
| D-dimer | 13 | 26 | 11 | 0 | 4 | 26 | 26 | 4 | 0.0003 |
Abbreviations: AG, aggravation; NR, no remission; PR, partial response; SR, significant remission.